ACR considers radiation exposure protection steps
The American College of Radiology is considering aggressive reforms that would ratchet up its direct involvement in programs and policies designed to protect the public and medical practitioners from ionizing radiation generated during medical imaging.
The American College of Radiology is considering aggressive reforms that would ratchet up its direct involvement in programs and policies designed to protect the public and medical practitioners from ionizing radiation generated during medical imaging.
In April, a blue ribbon panel headed by Dr. Steven Amis, chair of radiology at Albert Einstein College of Medicine, proposed 33 strategies intended to help control the growth in unnecessary radiation exposure to patients and medical personnel.
If it adopts the proposals, the ACR would for the first time support a standardized way to archive individual patient radiation data documenting exposure during medical imaging. The information would be collected and used by various groups to benchmark good medical practices and to identify patients who have accumulated high levels of radiation from frequent imaging sessions involving exposure to ionizing radiation. The information may be used to determine when alternative imaging should be recommended.
Reforms are directed at radiologists, referring physicians, physicists, manufacturers, insurers, and government regulators. They were published on the ACR website and in the May issue of the Journal of the American College of Radiology.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
